Why the study?
CAD limits life expectancy with most MI deaths occurring in people older than 70 years, prompting evaluation of the survival-improving potential of CABG in elderly patients compared to the age-matched general population.
Does coronary artery bypass grafting improve long-term survival in elderly patients (>70 years) compared to the age-matched general population?
Does coronary artery bypass grafting improve long-term survival in elderly patients (>70 years) compared to the age-matched general population?
CABG in elderly patients (>70 years) is associated with significantly better long-term survival compared to the age-matched general population, potentially eliminating the expected reduction in life expectancy from CAD.
Supports CABG consideration in selected elderly CAD patients; extends meta-analytic evidence on long-term survival beyond trial populations.
Coronary artery disease (CAD) limits life expectancy compared to the general population. Myocardial infarctions (MIs) are the primary cause of death. The incidence of MI increases progressively with age and most MI deaths occur in the population older than 70 years. Coronary artery bypass grafting (CABG) may prevent the occurrence of new MIs by bypassing most CAD lesions, providing downstream "collateralization" to the diseased vessel, and consequently prolonging survival. We systematically assessed the survival-improving potential of CABG by comparing elderly CABG patients to the age-matched general population.Three databases were assessed. The primary and single outcome was long-term all-cause mortality. Time-to-event data of the individual studies were extracted and reconstructed in an overall survival curve. As a sensitivity analysis, summary hazard ratios (HRs) and 95% confidence intervals (CIs) for all individual studies were pooled and meta-analytically addressed. The control group was based on the age-matched general population of each individual study.From 1,352 records, 4 studies (4,045 patients) were included in the analysis. Elderly patients (>70 years) who underwent CABG had a significantly lower risk of death in the follow-up compared to the general age-matched population in the overall survival analysis (HR: 0.88; 95% CI: 0.83, 0.94; p < 0.001: mean follow-up was 7 years).Elderly patients who undergo CABG appear to have significantly better long-term survival compared to the age-matched general population. This advantage becomes visible after the first year and underscores the life-prolonging effect of bypass surgery, which may eliminate the expected reduction in life expectancy through CAD.
No takes yet. Share an insight, caveat, or question.
Kirov et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: